科济药业-B(02171)10月23日斥资339.82万港元回购20.5万股
Core Viewpoint - Kintor Pharmaceutical Co., Ltd. announced a share buyback plan, indicating confidence in its stock value and future prospects [1] Group 1 - The company plans to repurchase 205,000 shares at a total cost of HKD 3.3982 million [1] - The buyback is scheduled for October 23, 2025, reflecting a strategic move to enhance shareholder value [1]